# FDA Inspection 846264 - Blood Center of New Jersey, The - August 29, 2013

Source: https://www.keypedia.com/records/fda_inspections/blood-center-of-new-jersey-the/af2f2a99-4994-4483-a404-8d0c977cdbff
Source feed: FDA_Inspections

> FDA Inspection 846264 for Blood Center of New Jersey, The on August 29, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846264
- Company Name: Blood Center of New Jersey, The
- Inspection Date: 2013-08-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 747272 - 2011-09-28](https://www.keypedia.com/records/fda_inspections/blood-center-of-new-jersey-the/b114ff95-332a-4559-afd5-078bb3570ef6)
- [FDA Inspection 555050 - 2008-12-11](https://www.keypedia.com/records/fda_inspections/blood-center-of-new-jersey-the/a9ce5a16-6735-4dd5-8189-a8e8438c2df4)

Company: https://www.keypedia.com/companies/blood-center-of-new-jersey-the/2ca9a435-8780-4bbf-b579-6c34c08c21f6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d